CRIS Current Research Information System

PADELLA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.604
NA - Nord America 4.526
EU - Europa 3.381
AF - Africa 305
Continente sconosciuto - Info sul continente non disponibili 260
SA - Sud America 197
OC - Oceania 7
Totale 13.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.426
VN - Vietnam 1.715
SG - Singapore 1.033
CN - Cina 954
GB - Regno Unito 869
IT - Italia 534
SE - Svezia 453
DE - Germania 403
HK - Hong Kong 248
FR - Francia 230
IN - India 171
NL - Olanda 163
RU - Federazione Russa 148
BR - Brasile 137
IE - Irlanda 131
JP - Giappone 91
FI - Finlandia 89
TG - Togo 81
ZA - Sudafrica 75
BD - Bangladesh 73
EE - Estonia 62
UA - Ucraina 58
CI - Costa d'Avorio 56
NG - Nigeria 56
CA - Canada 55
KR - Corea 55
BG - Bulgaria 53
CH - Svizzera 48
BE - Belgio 40
JO - Giordania 37
PH - Filippine 34
TH - Thailandia 32
AR - Argentina 28
ES - Italia 24
IQ - Iraq 24
MX - Messico 21
SC - Seychelles 19
ID - Indonesia 17
IR - Iran 15
TR - Turchia 15
AT - Austria 14
GR - Grecia 14
TW - Taiwan 14
UZ - Uzbekistan 13
PK - Pakistan 12
PL - Polonia 12
EC - Ecuador 9
EU - Europa 8
JM - Giamaica 8
MY - Malesia 8
CL - Cile 7
HR - Croazia 7
SA - Arabia Saudita 6
CO - Colombia 5
EG - Egitto 5
MK - Macedonia 5
PS - Palestinian Territory 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
LT - Lituania 4
PE - Perù 4
AZ - Azerbaigian 3
HN - Honduras 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
NI - Nicaragua 2
QA - Qatar 2
RO - Romania 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AL - Albania 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
Totale 13.017
Salva come PNG Salva come JPEG
Città #
Southend 789
Singapore 736
Dong Ket 684
Ashburn 556
Chandler 411
Fairfield 288
Ann Arbor 277
San Jose 263
Hong Kong 231
Ho Chi Minh City 227
Houston 191
Beijing 189
Hanoi 189
Wilmington 168
Seattle 149
Woodbridge 147
Dublin 130
Santa Clara 129
Princeton 126
Cambridge 115
Boardman 108
Bologna 106
New York 89
Tokyo 82
Lomé 81
Hefei 80
Los Angeles 74
Nanjing 66
Lauterbourg 62
Westminster 62
Padova 60
Medford 58
Abidjan 56
Helsinki 56
Munich 54
Sofia 53
Abeokuta 40
Da Nang 40
Brussels 39
Bern 36
Amman 35
Haiphong 35
Seoul 35
Dallas 34
Milan 32
Berlin 31
Turin 30
Bremen 29
Redwood City 29
Frankfurt am Main 28
Buffalo 27
Saint Petersburg 27
Hebei 26
São Paulo 26
Shanghai 25
Redondo Beach 24
Changsha 23
Jinan 23
Shenyang 23
Guangzhou 22
Nanchang 22
Florence 19
Jiaxing 19
Redmond 19
Paris 18
Rome 18
Lappeenranta 17
Toronto 17
Mountain View 16
Turku 16
Falkenstein 15
Hải Dương 15
San Diego 15
London 14
Council Bluffs 13
Montreal 13
Orem 13
Baghdad 12
Hangzhou 12
Johannesburg 12
Norwalk 12
Brooklyn 11
Falls Church 11
Tianjin 11
Biên Hòa 10
Chengdu 10
Chennai 10
Jakarta 10
Phoenix 10
Taizhou 10
Vienna 10
Bangkok 9
Chicago 9
Roubaix 9
Zhengzhou 9
Atlanta 8
Kingston 8
Manchester 8
Ningbo 8
Quận Ba 8
Totale 8.367
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 402
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 324
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 308
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 303
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 289
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 277
Alterations in phosphatidylinositol 3-phosphate (PI3P) pathway and cAMP pathway confirm poor prognosis and reduced overall survival (OS) in a series of 209 acute myeloid leukemia patients 265
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 257
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 254
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 252
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 250
Fanconi anemia gene variants in therapy-related myeloid neoplasms 250
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 236
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 235
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 234
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 230
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 214
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 213
Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis 212
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 209
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 206
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 206
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 204
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 200
Ex-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform 195
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 193
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 193
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 191
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 190
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 190
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 189
You have accessEx-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform 183
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 183
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions 181
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 180
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 179
An analysis pipeline for variant discovery in Whole Exome Sequencing data of cancer samples. 178
Clec12a: A new AML stem cell-associated antigen 178
A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 178
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 178
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 175
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 174
Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia 172
SNP array reveals a new deletion of JAK2 in AML patients 170
A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination 166
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 165
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 162
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs 160
Genomic wide microarray analysis identifies novel copy number alterations in adult acute myeloid leukemia 160
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 159
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 159
Aneuploidy: Cancer strength or vulnerability? 159
You have accessA New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 159
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 158
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis 157
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 156
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 154
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 154
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 153
Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia 152
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 148
Gene expression signature of aneuploidy in acute myeloid leukemia 144
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies 142
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin 142
Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients 131
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 129
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 125
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 106
Totale 13.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.468 171 44 79 142 154 80 41 80 79 87 275 236
2022/20231.682 189 240 98 227 120 131 54 72 286 46 138 81
2023/2024464 16 62 22 49 31 138 28 39 25 29 10 15
2024/20251.654 37 256 150 114 158 30 203 77 13 210 71 335
2025/20264.079 398 243 272 237 427 183 317 123 1.167 390 166 156
2026/2027110 110 0 0 0 0 0 0 0 0 0 0 0
Totale 13.280